Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 2 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Simcere Pharmaceutical Group, Pharmaceuticals &Healthcare, Deal Details | 12 | 17 |
| Partnerships | 12 | 1 |
| Laboratoires Merck Sharp Terminates Joint Venture with Simcere Pharma | 12 | 1 |
| Bristol-Myers Squibb Expands Co-Development Agreement With Simcere Pharma For Orencia | 13 | 2 |
| Bristol-Myers Squibb Expands Co-Development Agreement With Simcere Pharma For BMS-795311 | 15 | 2 |
| Simcere Pharma Enters Into Co-Development Agreement With Suzhou NeuPharma | 17 | 1 |
| Simcere Pharma Enters Into Co-Development Agreement With Nanjing Medical University | 18 | 1 |
| Bristol-Myers Squibb Enters Into Co-Development Agreement With Simcere Pharma For BMS-817378 | 19 | 1 |
| Simcere Pharma Plans To Enter Into Agreement With Western Companies | 20 | 1 |
| Licensing Agreements | 21 | 1 |
| Apexigen Enters into Licensing Agreement with Simcere Pharma for APX-003 | 21 | 1 |
| Equity Offering | 22 | 1 |
| Simcere Pharma May Raise up to USD128.9 Million in Public Offering of Shares | 22 | 1 |
| Asset Transactions | 23 | 1 |
| Simcere Pharma To Sell OTC Drug Division | 23 | 1 |
| Acquisition | 24 | 1 |
| Jinsheng Ren And Assure Ahead Investments Completes Acquisition Of Simcere Pharma For US$517 Million In Going Private Transaction | 24 | 2 |
| Zhuhai Rongding To Acquire Jilin Boda Pharma From Simcere Pharma For US$65 Million | 26 | 1 |
| Devont Asset Management To Acquire 35% Stake In Shanghai Celgen From Simcere Pharma For US$48 Million | 27 | 1 |
| Simcere Pharma Acquires Additional Stake in Jilin Boda Pharma | 28 | 1 |
| Simcere Pharmaceutical Group - Key Competitors | 29 | 1 |
| Key Employees | 30 | 1 |
| Locations And Subsidiaries | 31 | 2 |
| Head Office | 31 | 1 |
| Other Locations &Subsidiaries | 31 | 2 |
| Appendix | 33 | 1 |
| Methodology | 33 | 1 |
| About GlobalData | 33 | 1 |
| Contact Us | 33 | 1 |
| Disclaimer | 33 | 1 |